NTSR2 and B-cell chronic lymphocytic leukemia: Given that B-CLL lymphocytes exhibit apoptosis resistance, a hallmark of this disease, we sought to determine whether NTSR2 downregulation would sensitize B-CLL cells to programmed cell death.